IPO ChampIPO Insights
IPO Champ LogoIPO Champ Logo

IPOs

IPO Calendar
GMP Tracker
Subscription Status
Allotment Status
Stock Broker
  • Follow us on Instagram
  • Follow us on Facebook
  • Follow us on Threads
  • Follow us on YouTube
  • Follow us on Telegram
  • Follow us on WhatsApp
HomeIPOParas Healthcare

About Paras Healthcare

Paras Healthcare operates a hospital network providing tertiary and quaternary healthcare services. As of June 30, 2026, its network comprised eight hospitals with an aggregate capacity of 2,211 beds, spread across Haryana, Bihar, Uttar Pradesh, Rajasthan, Jharkhand and Jammu and Kashmir. Its hospitals serve markets including Gurugram, Panchkula, Patna, Darbhanga, Kanpur, Udaipur, Ranchi and Srinagar. The company focuses on complex clinical specialities comprising cardiac sciences, oncology, neurosciences, gastro sciences, orthopaedics and sports injury, and renal sciences, collectively termed “CONGOR”. These specialities contributed 74.7% of revenue in FY26 and 74.3% in Q1FY27. Its clinical infrastructure supports advanced procedures and intensive care, backed by a network-wide team of 1,084 doctors and 1,937 nurses as of June 30, 2026. The company differentiates its hospitals by operational maturity. Gurugram, Patna, Panchkula and Darbhanga constitute its mature facilities; Ranchi and Udaipur are classified as emerging hospitals; and Srinagar and Kanpur are classified as new hospitals. This portfolio combines established operations with facilities still increasing patient volumes. The company attributes its recent margin improvement partly to higher utilisation and operating leverage as emerging and new hospitals scale up. The network had 1,502 operational beds as of June 30, 2026. Occupancy increased from 50.7% in FY25 to 61.7% in FY26, reaching 69.7% in Q1FY27. Average revenue per occupied bed stood at ₹49,351.70 per day in Q1FY27. Occupied bed days were 338,321 in FY26, against 254,716 in FY24. Average length of stay improved from 3.14 days in FY24 to 2.93 days in FY26. In FY26, in-patient volume was 115,496 and out-patient volume was 778,707. Paras operates through owned, leased, revenue-sharing and public-private partnership arrangements. Its expansion pipeline includes a 300-bed hospital in Gurugram, targeted for launch in FY27, and a 500-bed hospital in Ludhiana, targeted for FY28. These additions would increase total bed capacity to 3,011 beds by March 31, 2028. The stated timelines are management targets and remain dependent on approvals, construction progress and resource availability. India’s healthcare delivery market is estimated at ₹7.6 to ₹7.8 lakh crore in FY26, compared with approximately ₹7.0 lakh crore in FY25. It projects the market to reach ₹11.2 to ₹12.2 lakh crore by FY30, representing 10% to 12% CAGR over FY25-FY30. Demand drivers include rising incomes, changing demographics, lifestyle-related ailments, medical tourism and government-supported healthcare access. These figures include estimates and forecasts. Within healthcare delivery, inpatient services account for a substantial share of expenditure because of the greater complexity and cost of treatment. The RHP’s industry assessment estimates inpatient services at 71% to 72% of the FY25 market and projects a 10.5% to 12.5% CAGR over FY25-FY30. This provides an industry backdrop for speciality hospitals, although translating demand into profitable growth requires adequate clinical staffing, efficient capacity deployment and timely collection of patient and payer dues. Now, Paras Healthcare is launching its Initial public offering (IPO), which consists of a fresh issue of ₹500 crore and an offer for sale of ₹950 crore. The total issue size of the IPO is ₹1,450 crore. Its shares will be listed on the NSE and BSE.

Live IPOs

National Stock Exchange of India logo

National Stock Exchange of India

Mainboard
Open  Close17th Sep 2026 - 21st Sep 2026
Issue Size22561.57 Cr
Min. Qty8 Shares
Issue Price₹ 1700.00
Live IPO
Antala Industries logo

Antala Industries

SME
Open  Close29th Oct 2026 - 5th Nov 2026
Issue Size22.98 Cr
Min. Qty2000 Shares
Issue Price₹ 62.00
Live IPO
Companies NameOpen - CloseIssue SizeMin. QtyIssue PriceApply
National Stock Exchange of India logo

National Stock Exchange of India

Mainboard
17th Sep 2026 - 21st Sep 202622561.57 Cr8 Shares₹ 1700.00
Antala Industries logo

Antala Industries

SME
29th Oct 2026 - 5th Nov 202622.98 Cr2000 Shares₹ 62.00
See All Live IPOs
IPO Champ LogoIPO Champ Logo

IPO Champ helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

Tools

IPO CalendarGMP TrackerSubscription StatusAllotment Status

IPOs

All IPOsLive IPOsUpcoming IPOsClosed IPOsListed IPOs

Resources

NewseBooks

Company

HomeAbout UsPrivacy PolicyTerms of Service

About IPO Champ

IPO Champ is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
help@ipochamp.com.

Please read all offer documents and risk disclosures carefully before investing. IPO Champ does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Champ. All rights reserved.

Want to stay updated?Subscribe to our newsletter

Paras Healthcare

Paras Healthcare

Open Date

Oct 21, 2026

Close Date

Oct 23, 2026

listed

Min Investment

₹14,553

Lot Size

21 Shares

Issue Size

₹1450 Cr

Price Range

₹660 - ₹660

Listing Date

Oct 28, 2026

IPO Doc

RHP PDF

Checklist Quality Analysis

Revenue Growth

Company Valuation

Earning Expansion

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily.

₹13(+1.88%)GMP
1.88%Prediction Listing Gain

Grey Market Premium (GMP) Trend

Paras Healthcare IPO - Issue Objectives

The company will use ₹320.90 crore for repayment of the loan availed by the business. The company will invest ₹54.10 crore in the subsidiary for repayment/prepayment of the loan. Part of the IPO proceeds will be used for general corporate purposes and issue expenses.

Repayment of loan

64.1%

Investment in subsidiary

10.8%

General corporate purposes

25%

1

Repayment of loan

The company will use ₹320.90 crore for repayment of the loan availed by the business.

64.10%
2

Investment in subsidiary

The company will invest ₹54.10 crore in the subsidiary for repayment/prepayment of the loan.

10.80%
3

General corporate purposes

Part of the IPO proceeds will be used for general corporate purposes and issue expenses.

25.00%

IPO Subscription Status

QIB
3.25x
NII
0.69x
Individual
2.10x
Total
2.34x

Times subscribed by category (bars capped at 10x for readability). Dashed line marks 1.0x (fully subscribed).

Financials of Paras Healthcare

In Cr.

Key Performance Indicator31-Mar-24 (In Cr.)31-Mar-22 (In Cr.)31-Mar-21 (In Cr.)
Revenue1,151.02936.05793.17
EBITDA
Expenses
Profit After Tax-15.33-42.79-14.81
Assets1,477.661,293.1963.53
Net Worth
Reserves
Borrowing

Paras Healthcare - Promoter(s)

Paras Healthcare

Pre Issue Share Holding

N/A

Post Issue Share Holding

N/A

About Strength & Risks

Why this IPO looks interesting

Key positives investors may want to consider before applying.

01

Established regional hospital network

Paras operates eight hospitals with 2,211 beds of total capacity, supported by an established presence in its selected markets. The combination of mature and developing hospitals provides both an operating base and scope for further utilisation improvements.

02

Speciality-led clinical offering

CONGOR specialities generated 74.7% of FY26 revenue. The focus on complex care, supported by specialist clinicians and advanced equipment, provides a foundation for differentiated clinical programmes and referral relationships.

03

Improving occupancy and operating leverage

Occupancy rose to 69.7% in Q1FY27, compared with 56.7% in Q1FY26. Operating EBITDA margin increased to 22.3% from 16.4% over the same periods, indicating that higher activity levels are translating into improved operating profitability.

What investors should watch closely

Risk factors and possible pressure points around the offer.

01

Profitability has been proven lately

Paras had losses of ₹(15.33) crore for FY24 and ₹(57.98) crore for FY25 but earned a profit of ₹43.83 crore for FY26. Expenses related to the launch of the new hospital and its expansion can further impact profitability. The profit in Q1FY27 has been positively affected by the deferred tax credit.

02

Debt and lease obligations

The total debt-to-equity ratio was 3.21x, including the leases, and 2.00x, excluding the leases. The borrowings under fund-based facilities as of June 30, 2026, stood at ₹939.47 crore. Issues related to financing and debt repayment are significant despite planned repayments.

Contact Details

Paras Healthcare

1 st Floor, Tower B, Paras Twin Towers, Golf Course Road, Sector 54, Gurugram, Haryana, 122002

+911244302163
cs@parashospitals.com
https://www.parashospitals.com/

Registrar Contact Details

Link Intime India Private Ltd

+91-22-4918 6270
parashealthcare.ipo@linkintime.co.in
https://linkintime.co.in/Initial_Offer/public-issues.html

Paras Healthcare IPO - FAQs

Paras Healthcare IPO is a Mainboard IPO. The issue is priced at 660-₹693. The minimum order quantity is 21 Shares. The IPO opens on 21 Oct, and closes on 23 Oct. Link Intime India Private Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.









IPO Timeline

  • Pre Apply2026-10-19
  • Bidding Starts2026-10-21
  • Bidding Ends2026-10-23
  • Allotment Finalisation2026-10-26
  • Release of Funds2026-10-27
  • Demat Transfer2026-10-27
  • Listing2026-10-28
04

Identified expansion pipeline

The planned Gurugram and Ludhiana hospitals would add 800 beds, taking total capacity to 3,011 beds by March 2028. This provides a defined growth pipeline, subject to timely commissioning, staffing and patient-volume development.

03

Government payer risk and collection

Schemes of government payers and PSU payers accounted for 41.2% of revenues in FY26. On average, the days of receivables in the current payer group were 153.23 days in FY26 and 166.69 days in Q1FY27.

04

Dependency on clinical and support staff

The attrition rate for professionals and other staff in the scope of attrition disclosure was 60.3% for FY26. Problems in retaining doctors, nurses, and other support staff may impact the delivery of healthcare services and recruitment expenses.

05

Risk associated with hospital expansion and commissioning

The firm has faced delay in launching operations at the hospitals already in place. Hospitals of Srinagar and Kanpur generated revenue 14 months and 12 months, respectively, behind the expected date.

06

Geographic concentration and scheme compliance

North Indian hospitals contributed 66.07% of FY26 revenue. Regional disruptions could therefore materially affect performance. Government-scheme participation also depends on compliance with billing, staffing, accreditation and other requirements; adverse actions can affect collections and patient volumes.